Hasil Pencarian - Ronan O'Hagan

  • Menampilkan 1 - 3 hasil dari 3
Perbaiki Hasil
  1. 1
    587 Tumor-activated Fc-engineered anti-CTLA-4 monoclonal antibody, XTX101, demonstrates tumor-selective PD and efficacy in preclinical models

    587 Tumor-activated Fc-engineered anti-CTLA-4 monoclonal antibody, XTX101, demonstrates tumor-selective PD and efficacy in preclinical models oleh John Williams, Wilson Guzman, Minjie Zhang, Parker Johnson, Megan McLaughlin, Kurt Jenkins, Caitlin O’Toole, Magali Pederzoli-Ribeil, Margaret Karow, Ronan O’Hagan, Jennifer O’Neil, Ugur Eskiocak, Miso Park, Timothy Clackson

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    568 XTX201, a protein-engineered IL-2, exhibits tumor-selective activity in mice without peripheral toxicities in non-human primates

    568 XTX201, a protein-engineered IL-2, exhibits tumor-selective activity in mice without peripheral toxicities in non-human primates oleh Wilson Guzman, Minjie Zhang, Parker Johnson, Megan McLaughlin, Kurt Jenkins, Hsin-Jung Wu, Hanumantha Rao Madala, Caitlin O’Toole, Magali Pederzoli-Ribeil, Raphael Rozenfeld, Huawei Qiu, Margaret Karow, Tim Clackson, Ronan O’Hagan, Jennifer O’Neil, Ugur Eskiocak

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    719 XTX301, a protein-engineered IL-12, exhibits tumor-selective activity in mice without peripheral toxicities and is well tolerated in non-human primates

    719 XTX301, a protein-engineered IL-12, exhibits tumor-selective activity in mice without peripheral toxicities and is well tolerated in non-human primates oleh Jia Chen, Wilson Guzman, Parker Johnson, Megan McLaughlin, Kurt Jenkins, Hanumantha Rao Madala, Magali Pederzoli-Ribeil, Huawei Qiu, Ekta Patel, Natalia Malkova, Sallyann Vu, Rebekah O'Donnell, Manoussa Fanny, Oleg Yerov, Caitlin O'Toole, Benjamin Nicholson, Bill Avery, Ronan O'Hagan, Jennifer O'Neil

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: